Teva Announces Strong Results For 2006

Israeli drugmaker Teva has announced record results for 2006, with sales rising by 60% to reach US$8.4bn. This dynamic performance was driven by the integration of IVAX - which Teva acquired at the beginning of 2006 in a deal worth US$7.8bn - with Q4 sales rising 63% to US$2.3bn, from a figure of US$1.4bn in the same period last year.

To read the full article, please choose one of the following options: